To view an abstract click on the title of the desired article. This will request Medline details from PubMed which is provided by the National Library of Medicine.
After viewing the abstract use your browser's [Back] button to return to this page.
Krona C, et al.
Screening for gene mutations in a 500 kb neuroblastoma tumor suppressor candidate region in chromosome 1p; mutation and stage-specific expression in UBE4B/UFD2.
Oncogene 2003 Apr 17;22(15):2343-51
[Related articles]  Screening
|
Stallings RL, et al.
Are gains of chromosomal regions 7q and 11p important abnormalities in neuroblastoma?
Cancer Genet Cytogenet 2003 Jan 15;140(2):133-7
[Related articles] |
Hogarty MD, et al.
No evidence for the presence of an imprinted neuroblastoma suppressor gene within chromosome sub-band 1p36.3.
Cancer Res 2002 Nov 15;62(22):6481-4
[Related articles] |
Van Roy N, et al.
Localization of the 17q breakpoint of a constitutional 1;17 translocation in a patient with neuroblastoma within a 25-kb segment located between the ACCN1 and TLK2 genes and near the distal breakpoints of two..
Genes Chromosomes Cancer 2002 Oct;35(2):113-20
[Related articles] Chromosome 17q
|
Spitz R, et al.
Fluorescence in situ hybridization analyses of chromosome band 1p36 in neuroblastoma detect two classes of alterations.
Genes Chromosomes Cancer 2002 Jul;34(3):299-305
[Related articles] |
Godfried MB, et al.
Lack of interstitial chromosome 1p deletions in clinically-detected neuroblastoma.
Eur J Cancer 2002 Jul;38(11):1513-9
[Related articles] |
Skog J, et al.
Human adenovirus serotypes 4p and 11p are efficiently expressed in cell lines of neural tumour origin.
J Gen Virol 2002 Jun;83(Pt 6):1299-309
[Related articles] |
Mora J, et al.
Evolving significance of prognostic markers associated with treatment improvement in patients with stage 4 neuroblastoma.
Cancer 2002 May 15;94(10):2756-65
[Related articles] MYCN Amplification Chromosome 17q
|
Teitz T, et al.
Caspase-9 and Apaf-1 are expressed and functionally active in human neuroblastoma tumor cell lines with 1p36 LOH and amplified MYCN.
Oncogene 2002 Mar 14;21(12):1848-58
[Related articles] MYCN Amplification
|
Abel F, et al.
Analyses of apoptotic regulators CASP9 and DFFA at 1P36.2, reveal rare allele variants in human neuroblastoma tumours.
Br J Cancer 2002 Feb 12;86(4):596-604
[Related articles] |
De Toledo M, et al.
The gene for a new brain specific RhoA exchange factor maps to the highly unstable chromosomal region 1p36.2-1p36.3.
Oncogene 2001 Nov 1;20(50):7307-17
[Related articles] |
Huang S, et al.
Reassignment of the EPB4.1 gene to 1p36 and assessment of its involvement in neuroblastomas.
Eur J Clin Invest 2001 Oct;31(10):907-914
[Related articles] |
Yang HW, et al.
Genomic structure and mutational analysis of the human KIF1B gene which is homozygously deleted in neuroblastoma at chromosome 1p36.2.
Oncogene 2001 Aug 16;20(36):5075-83
[Related articles] |
Chen YZ, et al.
Homozygous deletion in a neuroblastoma cell line defined by a high-density STS map spanning human chromosome band 1p36.
Genes Chromosomes Cancer 2001 Aug;31(4):326-32
[Related articles] |
Anderson J, et al.
Neuroblastoma in monozygotic twins--a case of probable twin-to-twin metastasis.
Br J Cancer 2001 Aug 17;85(4):493-6
[Related articles] MYCN Amplification
|
Bauer A, et al.
Smallest region of overlapping deletion in 1p36 in human neuroblastoma: A 1 Mbp cosmid and PAC contig.
Genes Chromosomes Cancer 2001 Jul;31(3):228-39
[Related articles] |
Spieker N, et al.
Three chromosomal rearrangements in neuroblastoma cluster within a 300-kb region on 1p36.1.
Genes Chromosomes Cancer 2001 Jun;31(2):172-81
[Related articles] |
Lastowska M, et al.
Comprehensive genetic and histopathologic study reveals three types of neuroblastoma tumors.
J Clin Oncol 2001 Jun 15;19(12):3080-90
[Related articles] MYCN Amplification Chromosome 17q
|
Gaitanou M, et al.
Cloning, expression and localization of human BM88 shows that it maps to chromosome 11p15.5, a region implicated in Beckwith-Wiedemann syndrome and tumorigenesis.
Biochem J 2001 May 1;355(Pt 3):715-24
[Related articles] |
Wei Yang H, et al.
Dna fragmentation factor 45 (dff45) gene at 1p36.2 is homozygously deleted and encodes variant transcripts in neuroblastoma cell line.
Neoplasia 2001 Mar-Apr;3(2):165-9
[Related articles] |
Caron H, et al.
Chromosome bands 1p35-36 contain two distinct neuroblastoma tumor suppressor loci, one of which is imprinted.
Genes Chromosomes Cancer 2001 Feb;30(2):168-174
[Related articles] |
Blatt J
Tumor suppressor genes on the short arm of chromosome 1 in neuroblastoma.
Pediatr Hematol Oncol 2001 Jan-Feb;18(1):3-5
[Related articles] |
White PS, et al.
Detailed molecular analysis of 1p36 in neuroblastoma.
Med Pediatr Oncol 2001 Jan;36(1):37-41
[Related articles] |
Vandesompele J, et al.
Multicentre analysis of patterns of DNA gains and losses in 204 neuroblastoma tumors: how many genetic subgroups are there?
Med Pediatr Oncol 2001 Jan;36(1):5-10
[Related articles] MYCN Amplification Chromosome 17q
|
Thompson PM, et al.
Homozygous deletion of CDKN2A (p16INK4a/p14ARF) but not within 1p36 or at other tumor suppressor loci in neuroblastoma.
Cancer Res 2001 Jan 15;61(2):679-86
[Related articles] |
Schilling FH, et al.
Absence of somatostatin receptor expression in vivo is correlated to di- or tetraploid 1p36-deleted neuroblastomas.
Med Pediatr Oncol 2001 Jan;36(1):56-60
[Related articles] |
Maris JM, et al.
Comprehensive analysis of chromosome 1p deletions in neuroblastoma.
Med Pediatr Oncol 2001 Jan;36(1):32-6
[Related articles] |
Ladenstein R, et al.
Prognostic significance of DNA di-tetraploidy in neuroblastoma.
Med Pediatr Oncol 2001 Jan;36(1):83-92
[Related articles] MYCN Amplification
|
Ichimiya S, et al.
Genetic analysis of p73 localized at chromosome 1p36.3 in primary neuroblastomas.
Med Pediatr Oncol 2001 Jan;36(1):42-4
[Related articles] |
Hogarty MD, et al.
Analysis of genomic imprinting at 1p35-36 in neuroblastoma.
Med Pediatr Oncol 2001 Jan;36(1):52-5
[Related articles] |
Hiyama E, et al.
Biological characteristics of neuroblastoma with partial deletion in the short arm of chromosome 1.
Med Pediatr Oncol 2001 Jan;36(1):67-74
[Related articles] |
Ejeskar K, et al.
Fine mapping of a tumour suppressor candidate gene region in 1p36.2-3, commonly deleted in neuroblastomas and germ cell tumours.
Med Pediatr Oncol 2001 Jan;36(1):61-6
[Related articles] |
Ambros PF, et al.
Intratumoural heterogeneity of 1p deletions and MYCN amplification in neuroblastomas.
Med Pediatr Oncol 2001 Jan;36(1):1-4
[Related articles] MYCN Amplification
|
Ambros PF, et al.
Intratumoural heterogeneity of 1p deletions and MYCN amplification in neuroblastomas.
Med Pediatr Oncol 2001 Jan;36(1):1-4
[Related articles] MYCN Amplification
|
Nakagawara A, et al.
Identification of the homozygously deleted region at chromosome 1p36.2 in human neuroblastoma.
Med Pediatr Oncol 2000 Dec 1;35(6):516-521
[Related articles] |
Hogarty MD, et al.
Identification of a 1-megabase consensus region of deletion at 1p36.3 in primary neuroblastomas.
Med Pediatr Oncol 2000 Dec 1;35(6):512-515
[Related articles] |
Benn DE, et al.
Sporadic and familial pheochromocytomas are associated with loss of at least two discrete intervals on chromosome 1p.
Cancer Res 2000 Dec 15;60(24):7048-51
[Related articles] |
Ohira M, et al.
Identification and characterization of a 500-kb homozygously deleted region at 1p36.2-p36.3 in a neuroblastoma cell line.
Oncogene 2000 Aug 31;19(37):4302-4307
[Related articles] |
Nagai M, et al.
Identification of the full-length KIAA0591 gene encoding a novel kinesin-related protein which is mapped to the neuroblastoma suppressor gene locus at 1p36.2.
Int J Oncol. 2000 May;16(5):907-16.
[Related articles] |
Maris JM, et al.
Loss of heterozygosity at 1p36 independently predicts for disease progression but not decreased overall survival probability in neuroblastoma patients: a Children's Cancer Group study.
J Clin Oncol. 2000 May;18(9):1888-99.
[Related articles] Trials & Studies
|
Jogi A, et al.
Patched 2, located in 1p32-34, is not mutated in high stage neuroblastoma tumors.
Int J Oncol. 2000 May;16(5):943-9.
[Related articles] |
Spieker N, et al.
An integrated 5-Mb physical, genetic, and radiation hybrid map of a 1p36.1 region implicated in neuroblastoma pathogenesis.
Genes Chromosomes Cancer. 2000 Feb;27(2):143-152.
[Related articles] |
Mora J, et al.
Clinical categories of neuroblastoma are associated with different patterns of loss of heterozygosity on chromosome arm 1p.
J Mol Diagn 2000 Feb;2(1):37-46
[Related articles] |
Ejeskar K, et al.
Fine mapping of the human preprocortistatin gene (CORT) to neuroblastoma consensus deletion region 1p36.3-->p36.2, but absence of mutations in primary tumors.
Cytogenet Cell Genet 2000;89(1-2):62-6
[Related articles] |
Wuyts W, et al.
Refined physical mapping and genomic structure of the EXTL1 gene.
Cytogenet Cell Genet. 1999;86(3-4):267-70.
[Related articles] |
Fan YS, et al.
Small terminal deletion of 1p and duplication of 1q: Cytogenetics, FISH studies, and clinical observations at newborn and at age 16 years.
Am J Med Genet. 1999 Sep;86(2):118-123.
[Related articles] |
Hadano S, et al.
Genomic organization of the human caspase-9 gene on Chromosome 1p36. 1-p36.3.
Mamm Genome. 1999; 10(7):757-60.
[Related articles] |
Olianas MC, et al.
[Phe1phi(CH2-NH)Gly2]nociceptin-(1-13)-NH2 acts as a partial agonist at ORL1 receptor endogenously expressed in mouse N1E-115 neuroblastoma cells.
Neuroreport. 1999 Apr 6;10(5):1127-31.
[Related articles] |
Lo Cunsolo C, et al.
Neuroblastoma in two siblings supports the role of 1p36 deletion in tumor development.
Cancer Genet Cytogenet. 1999 Mar;109(2):126-30.
[Related articles] |
Kaneko Y, et al.
Disomy 1 with terminal 1p deletion is frequent in mass-screening-negative/late-presenting neuroblastomas in young children, but not in mass-screening-positive neuroblastomas in infants.
Int J Cancer. 1999 Jan 5;80(1):54-9.
[Related articles] Screening
|
Ichimiya S, et al.
p73 at chromosome 1p36.3 is lost in advanced stage neuroblastoma but its mutation is infrequent.
Oncogene. 1999 Jan 28;18(4):1061-6.
[Related articles] |
Komuro H, et al.
Fluorescence in situ hybridization analysis of chromosome 1p36 deletions in human MYCN amplified neuroblastoma.
J Pediatr Surg. 1998 Nov;33(11):1695-8.
[Related articles] MYCN Amplification
|
Da Silva J, et al.
[Oncogenic factors of metastatic dissemination in neuroblastoma].
C R Seances Soc Biol Fil. 1998;192(2):261-71. Review. French.
[Related articles] |
Vandesompele J, et al.
Genetic heterogeneity of neuroblastoma studied by comparative genomic hybridization.
Genes Chromosomes Cancer. 1998 Oct;23(2):141-52.
[Related articles] Chromosome 17q
|
Sunahara M, et al.
Mutational analysis of the p73 gene localized at chromosome 1p36.3 in colorectal carcinomas. [1p36.3 region also frequently deleted in neuroblastoma]
Int J Oncol 1998 Aug;13(2):319-323
[Related articles] |
Grenet J, et al.
Duplication of the DR3 gene on human chromosome 1p36 and its deletion in human neuroblastoma.
Genomics. 1998 May 1;49(3):385-93.
[Related articles] |
Gotoh T, et al.
Human neuroblastoma demonstrating clonal evolution in vivo.
Genes Chromosomes Cancer. 1998 May;22(1):42-9.
[Related articles] MYCN Amplification
|
Roberts T, et al.
Molecular characterization of the 1p22 breakpoint region spanning the constitutional translocation breakpoint in a neuroblastoma patient with a t(1;10)(p22;q21).
Cancer Genet Cytogenet. 1998 Jan 1;100(1):10-20.
[Related articles] |
Roberts T; Cowell JK; Chernova O Molecular characterization of the 1p22 breakpoint region spanning the constitutional translocation breakpoint in a neuroblastoma patient with a t(1;10)(p22;q21).
Cancer Genet Cytogenet 1998 Jan 1;100(1):10-20
|
Bieche I, et al.
Deletion mapping in breast tumor cell lines points to two distinct tumor-suppressor genes in the 1p32-pter region, one of deleted regions (1p36.2) being located within the consensus region of LOH in neuroblasto
Oncol Rep. 1998 Jan-Feb;5(1):267-72.
[Related articles] |
Bieche I; Lidereau R; Khodja A Deletion mapping in breast tumor cell lines points to two distinct tumor-suppressor genes in the 1p32-pter region, one of deleted regions (1p36.2) being located within the consens
Oncol Rep 1998 Jan-Feb;5(1):267-72
|
White PS, et al.
Molecular analysis of the region of distal 1p commonly deleted in neuroblastoma.
Eur J Cancer. 1997 Oct;33(12):1957-61.
[Related articles] |
Van Roy N, et al.
Analysis of 1;17 translocation breakpoints in neuroblastoma: implications for mapping of neuroblastoma genes.
Eur J Cancer. 1997 Oct;33(12):1974-8.
[Related articles] Chromosome 17q
|
Tonini GP, et al.
Loss of heterozygosity for chromosome 1p in familial neuroblastoma.
Eur J Cancer. 1997 Oct;33(12):1953-6.
[Related articles] |
Rubie H, et al.
Loss of chromosome 1p may have a prognostic value in localised neuroblastoma: results of the French NBL 90 Study. Neuroblastoma Study Group of the Societe Francaise d'Oncologie Pediatrique (SFOP).
Eur J Cancer. 1997 Oct;33(12):1917-22.
[Related articles] |
Maris JM, et al.
Molecular genetic analysis of familial neuroblastoma.
Eur J Cancer. 1997 Oct;33(12):1923-8.
[Related articles] |
Maris JM, et al.
Human Kruppel-related 3 (HKR3): a candidate for the 1p36 neuroblastoma tumour suppressor gene?
Eur J Cancer. 1997 Oct;33(12):1991-6.
[Related articles] |
Martinsson T, et al.
Delimitation of a critical tumour suppressor region at distal 1p in neuroblastoma tumours.
Eur J Cancer. 1997 Oct;33(12):1997-2001.
[Related articles] |
Avigad S, et al.
Prognostic relevance of genetic alterations in the p32 region of chromosome 1 in neuroblastoma.
Eur J Cancer. 1997 Oct;33(12):1983-5.
[Related articles] |
Van Roy N, et al.
Comparative genomic hybridization analysis of human neuroblastomas: detection of distal 1p deletions and further molecular genetic characterization of neuroblastoma cell lines.
Cancer Genet Cytogenet. 1997 Sep;97(2):135-42.
[Related articles] Chromosome 17q
|
Lastowska M, et al.
Gain of chromosome arm 17q predicts unfavourable outcome in neuroblastoma patients. U.K. Children's Cancer Study Group and the U.K. Cancer Cytogenetics Group.
Eur J Cancer. 1997 Sep;33(10):1627-33.
[Related articles] Chromosome 17q
|
Kaghad M, et al.
Monoallelically expressed gene related to p53 at 1p36, a region frequently deleted in neuroblastoma and other human cancers.
Cell. 1997 Aug 22;90(4):809-19.
[Related articles] |
Ohtsu K, et al.
Clinical Investigation of Neuroblastoma with Partial Deletion in the Short Arm of Chromosome 1.
Clin Cancer Res. 1997 Jul;3(7):1221-1228.
[Related articles] |
Plantaz D, et al.
Gain of chromosome 17 is the most frequent abnormality detected in neuroblastoma by comparative genomic hybridization.
Am J Pathol. 1997 Jan;150(1):81-9.
[Related articles] Chromosome 17q
|
Caron H, et al.
Allelic loss of chromosome 1p as a predictor of unfavorable outcome in patients with neuroblastoma.
N Engl J Med. 1996 Jan 25;334(4):225-30.
[Related articles] |
O'Leary T, et al.
Loss of heterozygosity at 1p36 predicts poor prognosis in gastrointestinal stromal/smooth muscle tumors.
Lab Invest. 1999 Dec;79(12):1461-7.
[Related articles] |
Nomoto S, et al.
Frequent allelic imbalance suggests involvement of a tumor suppressor gene at 1p36 in the pathogenesis of human lung cancers.
Genes Chromosomes Cancer. 2000 Jul;28(3):342-346.
[Related articles] |
Mihara M, et al.
Absence of mutation of the p73 gene localized at chromosome 1p36.3 in hepatocellular carcinoma.
Br J Cancer. 1999 Jan;79(1):164-7.
[Related articles] |
Koesters R, et al.
Human Eukaryotic Initiation Factor EIF2C1 Gene: cDNA Sequence, Genomic Organization, Localization to Chromosomal Bands 1p34-p35, and Expression.
Genomics. 1999 Oct 15;61(2):210-218.
[Related articles] |
Bieche I, et al.
Deletion mapping of chromosomal region 1p32-pter in primary breast cancer.
Genes Chromosomes Cancer. 1999 Mar;24(3):255-63.
[Related articles] |
Neuroblastoma 1p - Publications
